Envista Holdings Corp
Envista Holdings Corp (NVST) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nvst · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Envista Holdings Corp (NVST) measures how much investors pay for each dollar of the company's trailing earnings. NVST's current PE ratio of 56.75x is calculated by dividing its stock price of $23.44 by its TTM earnings per share of $0.41. −6.0% discount vs 5Y avg 60.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 8 fiscal years · Front-end computedMinQ1 · 25%20.0x
MedianQ3 · 75%161.7x
Max
At 56.75x, NVST's current P/E is higher than in 75% of its annual fiscal year readings over the past 8 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Equipment & Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Envista Holdings CorpYou NVST | $3.8B | 56.75x | -97.6% | $0.41 |
 Alignment Healthcare, Inc. ALHC | $3.2B | N/A | — | -$0.00 |
 Apogee Therapeutics, Inc. APGE | $5.1B | N/A | — | -$4.22 |
 Concentra Group Holdings Parent, Inc. CON | $3.3B | 14.42x | -99.4% | $1.36 |
 Dyne Therapeutics, Inc. DYN | $2.8B | N/A | — | -$3.47 |
 GRAIL, Inc. GRAL | $2.6B | N/A | — | -$11.11 |
 ICU Medical, Inc. ICUI | $3.4B | 4802.44x | +99.4% | $0.03 |
Industry Average 2 peers with valid PE | — | 2408.43x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 77.60x | $0.28 | — | |
2024-12-31 FY2024 | — | $-6.50 | — | |
2023-12-31 FY2023 | — | $-0.60 | — | |
2022-12-31 FY2022 | 22.56x | $1.49 | +5.8% | |
2021-12-31 FY2021 | 21.33x | $2.11 | -86.8% | |
2020-12-31 FY2020 | 161.66x | $0.21 | +771.4% | |
2019-12-31 FY2019 | 18.55x | $1.60 | -1.0% | |
2018-12-31 FY2018 | 18.73x | $1.49 | +30.5% | |
2017-12-31 FY2017 | 14.35x | $1.95 | -9.7% | |
2016-12-31 FY2016 | 15.89x | $1.76 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Envista Holdings Corp (NVST) measures how much investors pay for each dollar of the company's trailing earnings. NVST's current PE ratio of 56.75x is calculated by dividing its stock price of $23.44 by its TTM earnings per share of $0.41.
Frequently asked questions
NVST pe ratio · 6 questionsNVST's current PE ratio is 56.75x as of 2026-06-08, based on a stock price of $23.44 and TTM EPS of $0.41. Data sourced from Financial Modeling Prep via NVST's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Envista Holdings Corp SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08